3-[4-(cyclohexylamino)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]-1,1,1-trifluoropropan-2-one
C23H24F3N3O3S — CID 58557912
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-(cyclohexylamino)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]-1,1,1-trifluoropropan-2-one
3-[4-(cyclohexylamino)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]-1,1,1-trifluoropropan-2-one (PubChem CID 58557912) has the molecular formula C23H24F3N3O3S and a molecular weight of 479.52 g/mol. Its IUPAC name is 3-[4-(cyclohexylamino)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]-1,1,1-trifluoropropan-2-one.
Molecular Properties
| Compound Name | 3-[4-(cyclohexylamino)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]-1,1,1-trifluoropropan-2-one |
|---|---|
| PubChem CID | 58557912 |
| Molecular Formula | C23H24F3N3O3S |
| Molecular Weight | 479.52 g/mol |
| Exact Mass | 479.15 |
| IUPAC Name | 3-[4-(cyclohexylamino)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]-1,1,1-trifluoropropan-2-one |
| SMILES | Cc1ccc(S(=O)(=O)n2ccc3c(NC4CCCCC4)c(CC(=O)C(F)(F)F)cnc32)cc1 |
| InChI | InChI=1S/C23H24F3N3O3S/c1-15-7-9-18(10-8-15)33(31,32)29-12-11-19-21(28-17-5-3-2-4-6-17)16(14-27-22(19)29)13-20(30)23(24,25)26/h7-12,14,17H,2-6,13H2,1H3,(H,27,28) |
| InChIKey | AKTLCXQISKOJFQ-UHFFFAOYSA-N |
| XLogP | 5.00 |
| TPSA | 81.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 479.52 |
| LogP ≤ 5 | 5.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58557912 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.